SyntheX
PrivateLast Round
Series A
Jan 11, 2024
Est. Valuation
$3.13M
Total Funding Raised
$18.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SyntheX is a biotechnology company that utilizes genetically engineered circuits and proprietary DNA-encoded libraries to discover novel therapeutics for cancer and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SyntheX Comparables
Compare SyntheX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxygen | 87% | |
| Degron Therapeutics | 83% | |
| Bullseye Biosciences | 82% |
SyntheX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 11, 2024 | ||||
| Debt | Apr 27, 2020 | ||||
| Seed | Apr 27, 2017 | ||||
| Seed | Feb 14, 2017 | ||||
| Accelerator | Jul 15, 2016 | ||||
Accelerator | Mar 1, 2016 |
SyntheX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morgan Noble Healthcare Partners | Series A |
| IndieBio | Seed, Accelerator |
| Oriza Ventures | Seed, Series A |
| OMX Ventures | Seed, Series A |
| 8VC | Seed, Series A |
| SOSV | Accelerator, Seed, Series A |
| SVB Financial Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2026
Grew 18% QoQ, from 34 to 40 employees.
SyntheX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SyntheX's valuation, stock price, and market status.
Is SyntheX a public or private company?
SyntheX is a private company.
What is the current stock price of SyntheX?
SyntheX is a private company with no public stock price. No recent secondary market data is available.
How much is SyntheX worth (valuation)?
Valuation information for SyntheX is not publicly available.
Can I buy SyntheX stock?
SyntheX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SyntheX's last funding round?
SyntheX's most recent funding round was Series A on January 11, 2024.
Who are the main investors in SyntheX?
Key investors in SyntheX include IndieBio.
Will SyntheX IPO soon?
No public IPO plans have been announced for SyntheX.
How can I track SyntheX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SyntheX's secondary market activity and sign up for updates.